Anaesthesia and climate change: time to wake up? A rapid qualitative appraisal exploring the views of anaesthetic practitioners regarding the transition to TIVA and the reduction of desflurane.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 25 02 2024
accepted: 23 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

The National Health Service (NHS) has pledged to reach carbon net-zero by 2040. In alignment with this goal, a London hospital's anaesthesia department is actively reducing desflurane use and transitioning towards total intravenous anaesthesia (TIVA) as a sustainable alternative, contributing to environmentally responsible practices within the healthcare sector. We conducted a rapid qualitative appraisal through online interviews with 17 anaesthetic practitioners to explore their perspectives regarding this climate change mitigation strategy. Data analysis was undertaken through the use of rapid appraisal sheets and a framework analysis method. Participants highlighted the disadvantages of TIVA, including the increased effort, heightened monitoring requirements, operational challenges, and a lack of clinical confidence associated with its use. Despite these reservations, participants acknowledged TIVA's potential to reduce postoperative nausea. There were perceptions that senior staff members might resist this change due to habits and scepticism over its impact on climate change. To facilitate greater TIVA adoption, participants recommended enhanced training, the implementation of a dashboard to raise awareness of greenhouse gas (GHG) emissions, and the presence of strong climate change leadership within the department. Participants believed that a shift to TIVA should be followed by specific measures such as addressing waste management which is crucial for GHG reduction, emphasising the perceived link between waste and emissions. The evaluation examines stakeholder attitudes, perceptions, and behaviours, focusing on transitioning from desflurane to TIVA. The study highlights the importance of staff engagement, organisational support, and underscores the crucial role that healthcare practitioners and leadership play in fostering sustainability within the healthcare sector.

Sections du résumé

BACKGROUND BACKGROUND
The National Health Service (NHS) has pledged to reach carbon net-zero by 2040. In alignment with this goal, a London hospital's anaesthesia department is actively reducing desflurane use and transitioning towards total intravenous anaesthesia (TIVA) as a sustainable alternative, contributing to environmentally responsible practices within the healthcare sector.
METHODS METHODS
We conducted a rapid qualitative appraisal through online interviews with 17 anaesthetic practitioners to explore their perspectives regarding this climate change mitigation strategy. Data analysis was undertaken through the use of rapid appraisal sheets and a framework analysis method.
RESULTS RESULTS
Participants highlighted the disadvantages of TIVA, including the increased effort, heightened monitoring requirements, operational challenges, and a lack of clinical confidence associated with its use. Despite these reservations, participants acknowledged TIVA's potential to reduce postoperative nausea. There were perceptions that senior staff members might resist this change due to habits and scepticism over its impact on climate change. To facilitate greater TIVA adoption, participants recommended enhanced training, the implementation of a dashboard to raise awareness of greenhouse gas (GHG) emissions, and the presence of strong climate change leadership within the department. Participants believed that a shift to TIVA should be followed by specific measures such as addressing waste management which is crucial for GHG reduction, emphasising the perceived link between waste and emissions.
CONCLUSIONS CONCLUSIONS
The evaluation examines stakeholder attitudes, perceptions, and behaviours, focusing on transitioning from desflurane to TIVA. The study highlights the importance of staff engagement, organisational support, and underscores the crucial role that healthcare practitioners and leadership play in fostering sustainability within the healthcare sector.

Identifiants

pubmed: 39215241
doi: 10.1186/s12871-024-02693-5
pii: 10.1186/s12871-024-02693-5
pmc: PMC11363533
doi:

Substances chimiques

Desflurane CRS35BZ94Q
Anesthetics, Inhalation 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300

Subventions

Organisme : BMBR MRC grant
ID : MR/W029766/1
Organisme : NIHR Central London Patient Safety Research Collaboration (CL PSRC)
ID : NIHR204297

Informations de copyright

© 2024. The Author(s).

Références

Anaesthesia. 2024 Mar;79(3):309-317
pubmed: 38205529
Soc Sci Med. 2017 Sep;189:63-75
pubmed: 28787628
BMC Health Serv Res. 2023 Apr 20;23(1):384
pubmed: 37081553
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Lancet Planet Health. 2017 Dec;1(9):e381-e388
pubmed: 29851650
Curr Opin Anaesthesiol. 2011 Apr;24(2):182-7
pubmed: 21252648
Qual Health Res. 2020 Aug;30(10):1596-1604
pubmed: 32667277
Anaesth Intensive Care. 2018 May;46(3):332-338
pubmed: 29716493
Milbank Q. 2021 Dec;99(4):1024-1058
pubmed: 34402553
Anaesthesia. 2022 Feb;77(2):201-212
pubmed: 34724710
Implement Sci. 2021 Jul 2;16(1):67
pubmed: 34215286
J Med Syst. 2020 Aug 13;44(9):169
pubmed: 32794038
Environ Sci Technol. 2015 Feb 3;49(3):1779-86
pubmed: 25517602
Curr Environ Health Rep. 2018 Mar;5(1):197-204
pubmed: 29423661
Br J Anaesth. 2010 Dec;105(6):760-6
pubmed: 20935004
Lancet Planet Health. 2020 Nov;4(11):e538-e543
pubmed: 33159881
J Clin Anesth. 2018 Mar;45:6-11
pubmed: 29223575
Anesth Analg. 2021 Oct 1;133(4):826-835
pubmed: 33857027
J Med Ethics. 2023 Mar;49(3):204-210
pubmed: 35459742
Lancet Planet Health. 2017 Sep;1(6):e216-e217
pubmed: 29851604

Auteurs

Syka Iqbal (S)

Department of Targeted Intervention, University College London (UCL), Charles Bell House, 43-45 Foley Street, London, W1W 7TY, UK.
Department of Psychology, University of Bradford, Bradford, UK.

Amelia Karia (A)

Department of Targeted Intervention, University College London (UCL), Charles Bell House, 43-45 Foley Street, London, W1W 7TY, UK.

Damon Kamming (D)

University College London Hospitals NHS Foundation Trust (UCLH), London, UK.

Daniel Herron (D)

University College London Hospitals NHS Foundation Trust (UCLH), London, UK.

Luke O'Shea (L)

University College London Hospitals NHS Foundation Trust (UCLH), London, UK.

Cecilia Vindrola-Padros (C)

Department of Targeted Intervention, University College London (UCL), Charles Bell House, 43-45 Foley Street, London, W1W 7TY, UK. c.vindrola@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH